AGP Executive Report
Last update: 7 hours agoTrauma & Cravings: A Hebrew University study links reminders of collective trauma (Oct. 7) to an immediate spike in cannabis cravings for regular users, with similar effects seen in tobacco smokers. Medical Cannabis Research: University of Arizona work points to cannabis aroma compounds (terpenes) that may ease fibromyalgia and post-surgical pain without the THC “high,” while a separate study on hypermobility patients reports fewer opioids and less pain after cannabis-based medicinal products. Policy Watch: Himachal Pradesh is moving ahead with regulated cannabis cultivation for industrial and medicinal use, aiming to boost farmer income and create new textile/cosmetics/pharma pathways. Legal & Courts: A Court of Appeal ruling in Malaysia is reigniting calls to amend drug laws to allow bail discretion in cannabis trafficking cases. Public Health & Safety: UK reporting highlights a cannabis-driving case with a ban after THC exceeded the legal limit. Industry Signals: A new trial begins for PP-01 to help mitigate cannabis withdrawal symptoms in patients with cannabis use disorder.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Cannabis in Oncology Nursing: Reducing Polypharmacy and Managing Symptoms]]>](https://cdn.sanity.io/images/0vv8moc6/oncnurse/fd0ace1d084f9b0aef0c98a08b0a7fb98027f032-1920x1080.jpg)
